Premier Alternatives

Duo Oncology

Pittsburgh, PA · Founded 2020 · Privately Held (backing)

Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments. Duo Oncology is based in Pittsburgh, PA and was founded in 2020. It was valued at $25 million at its seed round in Jun 2025, the last priced event on record. It has raised $13.1 million across 3 recorded rounds; the latest was a $1.4 million seed round in Jun 2025.

PMV mark · valuation
$25.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$13.1M
Last round
Seed Round
Jun 2025

Duo Oncology key facts

as of Oct 2026
  • Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments.
  • Duo Oncology is valued at approximately $25.0M as of Oct 2026, set at its seed round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $13.1M across 3 recorded rounds; the latest was Seed Round ($1.4M) in Jun 2025.
  • Notable investors include Innovation Works, Ulu Ventures, SeedFolio, BeOne Medicines, LifeX Ventures — 10 tracked in total.
  • Duo Oncology has filed 4 Form Ds with the SEC since 2021, most recently Jun 2025 ($400K sold to 8 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$25.0M

Valued at $25.0M at its seed round, Jun 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Duo Oncology with a free account
  • ·Watch Duo Oncology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Duo Oncology funding rounds

3 rounds
Jun 2025Seed Round$1.4MSEC filing▮
Jan 2023Seed Round$4.3MSEC filing▮
Feb 2021Seed Round$1.1MSEC filing▮
Full funding history →

Duo Oncology valuation

Duo Oncology was valued at $25 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Duo Oncology raised?

Duo Oncology has raised $13.1 million across 3 recorded rounds since 2021. The largest was a $4.3 million seed round in Jan 2023; the most recent was a $1.4 million seed round in Jun 2025.

Duo Oncology has filed 4 Form Ds with the SEC since 2021, most recently in Jun 2025 ($400,000 sold to 8 investors).

Duo Oncology investors

10 investors are on record for Duo Oncology, including Innovation Works, Ulu Ventures, SeedFolio and BeOne Medicines. The seed round in Jun 2025 drew 13 investors.

About Duo Oncology

Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments. The company offers targeted, next-generation cancer therapies with reduced toxicity and improved selectivity, enabling patients with aggressive cancers to receive effective treatment with fewer debilitating side effects.

Sector
Healthcare
HQ
Pittsburgh, PA, United States
Founded
2020
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.